在2020年10月至2021年6月期间,在德国的日托儿童与成年人之间,SARS-CoV-2血清转化
Ulrike Kubisch1, Anna Sandoni2, Juliane Wurm2
1Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany. kubischu@rki.de.
Communications medicine
|September 15, 2023
概括
幼儿的SARS-CoV-2血清转换率高于成年人. 高病毒载量和延迟的抗体测试与血清转化相关,这表明儿童在感染后发生了抗体的发展.
科学领域:
- 儿童传染病 儿童传染病
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 关于6岁以下儿童的SARS-CoV-2血清转化率的数据有限.
- 这项研究通过比较幼儿和成人血清转换来解决信息稀缺的问题.
研究的目的:
- 为了比较幼儿和成人之间的SARS-CoV-2血清转化率.
- 为了确定与SARS-CoV-2感染个体的血清转化相关的因素.
主要方法:
- 这项COALA研究分析了日托中心和家庭中SARS-CoV-2的传播情况.
- PCR阳性个体 (n=91,包括38名1-6岁儿童) 在5周内采集的两份血液样本中测试了IgG抗体.
主要成果:
- 小孩子的血清转化率 (97.4%) 与成年人 (66%) 相比显著更高.
- 较高的病毒载荷和感染和抗体测试之间的较长间隔与血清转化有关.
结论:
- 在SARS-CoV-2感染后,幼儿表现出大量的特定抗体发育.
- 这种抗体反应可能在这个年龄组中提供临时保护,防止再次感染或严重疾病.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Prevalence and Incidence
621
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
621
Vaccinations
44.7K
Overview
44.7K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


